Daseke — FY2021 Earnings Presentation
25 slides from Daseke's earnings presentation, Jan 25, 2022
Slide 1: Q4 and Full Year 2021 Earnings Presentation
Exhibit 99.1 Q4 and Full Year 2021 Earnings Presentation January 25, 2022
Slide 2: Important Disclaimers
Important Disclaimers Forward‐Looking Statements that provide guidance as to the effect the COVID‐19 global pandemic may have, and, as a result, the ultimate impact of the pandemic is highly uncertain and subject to change. Daseke defines: This presentation contains “forward‐looking statements” with
Slide 3: Q4 and FY 2021: Key Highlights (Excluding Aveda)
Q4 and FY 2021 : Key Highlights (Excluding Aveda) (1) Imbalanced supply / demand continues Revenue Adj. EBITDA Adj. Net Income to be supportive to freight rates; niche capabilities and superior service garner a $1,556.8M $394.3M $223.1M $49.6M $77.8M $13.0M 2021 Q4 2021 2021 Q4 2021 2021 Q4 2021 p
Slide 4: Consolidated Financial Results
Consolidated Financial Results ($ in millions) Excluding Aveda Quarter ended Dec. Quarter ended Dec. 2021 4Q ‘21 4Q ‘20 %▲ 2021 4Q ’21 4Q ‘20 %▲ Total Revenue $394.3 $335.6 17.5% Total Revenue $394.3 $335.6 17.5% Revenue (excl. FSC) $357.8 $314.0 13.9% Revenue (excl. FSC) $357.8 $314.0 13.9% Operati
Slide 5: Consolidated Financial Results
Consolidated Financial Results ($ in millions) Excluding Aveda FY 2021 Results 2021 2020 %▲ FY 2021 Results 2021 2020 %▲ Total Revenue $1,556.8 $1,454.1 7.1% Total Revenue $1,556.8 $1,402.4 11.0% Revenue (excl. FSC) $1,424.4 $1,357.4 4.9% Revenue (excl. FSC) $1,424.4 $1,305.7 9.1% Operating Income $
Slide 6: Specialized Financial Metrics
Specialized Financial Metrics Q4 2021 Results (Quarter ended Dec 31; $ in Millions, except Rate per Mile and Revenue per Tractor) Specialized Segment: Q4 2021 Q4 2020 %▲ Defensible Advantages Revenue $220.3 $196.5 12.1% Operating Ratio 92.4% 92.8% (40 bps) • Embrace Complexity Adj. Operating Ratio 9
Slide 7: Specialized Financial Metrics (Excluding Aveda)
Specialized Financial Metrics (Excluding Aveda) Strong demand and tight capacity drive revenue growth, supported by High Security Cargo and Construction end markets Specialized Rates (ex-Aveda) Adjusted EBITDA growth despite lower wind energy $70.3 K revenues reflects targeted diversity of end m
Slide 8: Flatbed Financial Metrics
Flatbed Financial Metrics Flatbed Rates Revenue growth continues to reflect strong market rates, $55.5 K $56.0 K $2.70 $51.3 K $60.00 particularly in steel, construction & manufacturing $2.50 $45.7 K $55.00 $43.0 K $2.57 $50.00 $2.30 $2.50 $2.50 $45.00 Achieve premium rates compared to overall F
Slide 9: Capital Summary & Free Cash Flow
Capital Summary & Free Cash Flow Free Cash Flow & Financed CAPEX ($ in millions) Capital Summary ($ in millions) As of December 31, 2021 Cash $147.5 Revolving line of credit availability $107.8 Available liquidity(1) $255.3 Net Debt $447.0 (1) Available liquidity is the sum of cash plus revolving li
Slide 10: 2022 Outlook
2022 Outlook Assumptions and Outlook • Tailwinds: Increased industrial demand & operational 2022 Outlook initiatives Revenue Growth % 4% - 7% • Headwinds: Inflationary pressure on costs including driver pay, salaries, recruiting, and operating costs Adjusted EBITDA Growth % 5% - 10% • Other Qualitat
Slide 11: Daseke Progress in Review
Daseke Progress in Review 2019 2020 2021 Forward EV/EBITDA – Daseke vs. Peer Group 28% Discount to Peers 28% Discount to Peers 31% Discount to Peers Fleet Size(1) 5,685 5,220 4,814 Adj. OR%(1) 96.4% 93.6% 90.9% Adj. EBITDA Margin(1) 10.2% 12.7% 14.3% Debt / Equity(2) 3.5x 1.8x 0.9x Adj. EBITDA less
Slide 12: Multiple Ways For Daseke To Win
Multiple Ways For Daseke To Win Focus on continuous improvement Continued and consistent EBITDA (with an emphasis on operating income) improvement to drive sustainable growth and margin expansion Thoughtful and disciplined approach towards implementation of business improvement plans and cross-p
Slide 13: Financial Tables & Reconciliations
Financial Tables & Reconciliations 13
Slide 14: Financial Reconciliations
Financial Reconciliations Daseke, Inc. and Subsidiaries Reconciliation of Net Income (Loss) to Adjusted EBITDA ex‐Aveda by Segment Reconciliation of Net Income (Loss) Margin to Adjusted EBITDA ex‐Aveda Margin by Segment (Unaudited) (In millions) Three Months Ended Year Ended December 31, 2021 Decemb
Slide 15: Financial Reconciliations
Financial Reconciliations Daseke, Inc. and Subsidiaries Reconciliation of Net Income (Loss) to Adjusted EBITDA ex‐Aveda by Segment Reconciliation of Net Income (Loss) Margin to Adjusted EBITDA ex‐Aveda Margin by Segment (Unaudited) (In millions) Three Months Ended Year Ended December 31, 2020 Decemb
Slide 16: Financial Reconciliations
Financial Reconciliations Daseke, Inc. and Subsidiaries Reconciliation of Net Loss to Adjusted EBITDA ex‐Aveda Reconciliation of Net Loss Margin to Adjusted EBITDA ex‐Aveda Margin (Unaudited) (In millions) Year ended December 31, 2019 Consolidated Net loss $ (307.4) Depreciation and amortization 146
Slide 17: Financial Reconciliations
Financial Reconciliations Daseke, Inc. and Subsidiaries Reconciliation of Net Income (Loss) to Adjusted Net Income ex‐Aveda Reconciliation of Net Income (Loss) to Net Income (Loss) ex‐Aveda Reconciliation of Earnings Per Share to Adjusted Earnings Per Share ex‐Aveda (Unaudited) (In millions, except
Slide 18: Financial Reconciliations
Financial Reconciliations Daseke, Inc. and Subsidiaries Reconciliation of Earnings Per Share to Adjusted Earnings Per Share ex‐Aveda (continued) (Unaudited) (In millions, except share and per share data) Three Months Ended December 31, Year Ended December 31, 2021 2020 2021 2020 Adjusted Net Income
Slide 19: Financial Reconciliations
Financial Reconciliations Daseke, Inc. and Subsidiaries Reconciliation of Operating Ratio to Adjusted Operating Ratio ex‐Aveda Reconciliation of Operating Income to Adjusted Operating Income ex‐Aveda Reconciliation of Revenue to Revenue ex‐Aveda (Unaudited) (In millions) Three Months Ended December
Slide 20: Financial Reconciliations
Financial Reconciliations Daseke, Inc. and Subsidiaries Reconciliation of Operating Ratio to Adjusted Operating Ratio ex‐Aveda Reconciliation of Operating Income to Adjusted Operating Income ex‐Aveda Reconciliation of Revenue to Revenue ex‐Aveda (Unaudited) (In millions) Year Ended December 31, 2021
Slide 21: Financial Reconciliations
Financial Reconciliations Daseke, Inc. and Subsidiaries Reconciliation of Operating Ratio to Adjusted Operating Ratio ex‐Aveda Reconciliation of Operating Loss to Operating Loss ex‐Aveda Reconciliation of Revenue to Revenue ex‐Aveda (Unaudited) (In millions) Year ended December 31, 2019 Consolidated
Slide 22: Financial Reconciliations
Financial Reconciliations Daseke, Inc. and Subsidiaries Reconciliation of net cash provided by operating activities to Free Cash Flow (Unaudited) (In millions) Three Months Ended Year Ended December 31, December 31, 2021 2020 2021 2020 Net cash provided by operating activities $ 29.0 $ 22.5 $ 144.7
Slide 23: Financial Reconciliations
Financial Reconciliations Daseke, Inc. and Subsidiaries Reconciliation of total debt to net debt (Unaudited) (In millions) As of December 31, 2021 2020 Term Loan Facility $ 397.0 $ 483.5 Equipment term loans 169.0 164.9 Finance lease obligations 28.5 31.3 Total debt 594.5 679.7 Less: cash and cash e
Slide 24: Financial Reconciliations
Financial Reconciliations Daseke, Inc. and Subsidiaries Reconciliation of Adjusted EBITDA to Adjusted EBITDA less Net Cash Capex (Unaudited) (In millions) Years ended December 31, 2019 2020 2021 Adjusted EBITDA (see slides 14, 15 and 16 for reconciliation from net (loss) income) $ 170.9 $ 175.8 $ 21
Slide 25: Contact Information
Contact Information Daseke, Inc. 15455 Dallas Parkway, Ste 550 Addison, TX 75001 www.Daseke.com Investor Relations Joe Caminiti or Ashley Gruenberg Alpha IR Group 312‐445‐2870 DSKE@alpha‐ir.com 25